Neuromuscular-targeting compound 1 |
| Katalog-Nr.GC31174 |
Die neuromuskulÄr zielende Verbindung 1, extrahiert aus dem Patent WO2009099594 A1, Paragraph 0100, ist nÜtzlich bei der Behandlung von neuromuskulÄren Erkrankungen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1178978-20-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Neuromuscular-targeting compound 1, extracted from patent WO2009099594 A1, Paragraph 0100, is useful in treatment of neuromuscular diseases.
[1]. YANG, Zhe, et al. CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS. WO2009099594A1.
Average Rating: 5 (Based on Reviews and 29 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *